Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.

Kapoor S.

Cancer Chemother Pharmacol. 2013 Apr;71(4):1101. doi: 10.1007/s00280-013-2072-6. Epub 2013 Feb 6. No abstract available.

PMID:
23385781
2.

Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.

Cheng CY, Cherng SH, Wu WJ, Yang TY, Huang XY, Liao FT, Wu MF, Sheu GT.

Cancer Chemother Pharmacol. 2013 Apr;71(4):1103-4. doi: 10.1007/s00280-013-2085-1. No abstract available.

PMID:
23377309
3.

Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells.

Cheng CY, Cherng SH, Wu WJ, Yang TY, Huang XY, Liao FT, Wu MF, Sheu GT.

Cancer Chemother Pharmacol. 2012 Jan;69(1):145-54. doi: 10.1007/s00280-011-1682-0. Epub 2011 Jun 1.

PMID:
21630085
4.

Clusterin immunoexpression and its clinical significance in patients with non-small cell lung cancer.

Li H, Liu S, Zhu X, Yang S, Xiang J, Chen H.

Lung. 2010 Oct;188(5):423-31. doi: 10.1007/s00408-010-9248-1. Epub 2010 Jul 8.

PMID:
20614220
5.

p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells.

Lai SL, Perng RP, Hwang J.

J Biomed Sci. 2000 Jan-Feb;7(1):64-70.

PMID:
10644891
6.

New cytotoxics.

Crinò L.

Lung Cancer. 2002 Oct;38(1):S41-2. No abstract available.

PMID:
12367814
7.

EGFR inhibition in non-small cell lung cancer: resistance, once again, rears its ugly head.

Clark J, Cools J, Gilliland DG.

PLoS Med. 2005 Mar;2(3):e75. Epub 2005 Feb 22. No abstract available.

8.

[Chemosensitivity test for unresectable non-small cell lung cancer].

Kawamura M, Inoue Y, Oyama T, Kobayashi K.

Nihon Geka Gakkai Zasshi. 2002 Feb;103(2):229-32. Japanese.

PMID:
11904985
9.

[Biological therapy in non-small-cell lung cancer (NSCLC)].

Souquet PJ.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S53-4S56. Review. French. No abstract available.

PMID:
15687996
10.

Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?

Keller JA, Erson-Bensan AE, Petty EM.

Cancer Biol Ther. 2010 Nov 1;10(9):942-4. doi: 10.4161/cbt.10.9.13876. Epub 2010 Nov 1. No abstract available.

PMID:
21057211
11.

New drugs in non-small cell lung cancer.

Comella P; Southern Italy Cooperative Oncology Group (SICOG).

Tumori. 2000 Sep-Oct;86(5 Suppl 1):S47-50. Review. No abstract available.

PMID:
11195295
12.

Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

July LV, Beraldi E, So A, Fazli L, Evans K, English JC, Gleave ME.

Mol Cancer Ther. 2004 Mar;3(3):223-32.

13.

[Treatment of lung cancer: critical review of new agents].

Spataro V.

Rev Med Suisse. 2005 Feb 23;1(8):575-81. Review. French. No abstract available.

PMID:
15794308
14.

[Erlotinib. A new option for non-small cell lung cancer].

Polk B.

Med Monatsschr Pharm. 2006 Jan;29(1):4-6. Review. German. No abstract available.

PMID:
16463547
15.

[Local and systemic therapy of non-small cell lung carcinoma (NSCLC)].

Gatzemeier U, Griesinger F, Huber RM, Thomas M.

Onkologie. 2010;33 Suppl 5:1. doi: 10.1159/000313970. Epub 2010 May 14. German. No abstract available.

16.

RB protein status and chemosensitivity in non-small cell lung cancers.

Yamamoto Y, Shimizu E, Masuda N, Takada M, Sone S.

Oncol Rep. 1998 Mar-Apr;5(2):447-51.

PMID:
9468577
17.

Neuroendocrine phenotype, chemosensitivity and prognosis in adenocarcinoma of the lung.

Souhami RL.

Ann Oncol. 1991 May;2(5):323-4. No abstract available.

PMID:
1659448
18.

Discussion.

[No authors listed]

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1175. doi: 10.1016/j.jtcvs.2012.07.048. Epub 2012 Aug 24. No abstract available.

19.

Non-small cell lung cancer: from targeted therapy to tailored therapy.

Malgieri S, Feliciano S, Bosso D, Federico P, Palmieri G, De Placido S, Di Lorenzo G, Buonerba C.

Expert Opin Pharmacother. 2012 Sep;13(13):1817-9. doi: 10.1517/14656566.2012.707645. Epub 2012 Jul 18. No abstract available.

PMID:
22803703
Items per page

Supplemental Content

Write to the Help Desk